Literature DB >> 10620567

Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population.

M Garcia-Barceló1, L Y Chow, H F Chiu, Y K Wing, D T Lee, K L Lam, M M Waye.   

Abstract

BACKGROUND: The cytochrome P450 CYP2D6 enzyme debrisoquine 4-hydroxylase metabolizes many different classes of commonly used drugs, such as tricyclic antidepressants and neuroleptics. Genetic polymorphism of the CYP2D6 gene is responsible for pronounced interindividual and interracial differences in the metabolism of these drugs. The CYP2D6*10 allele and its variants are the most frequent alleles found in Orientals, and they are responsible for diminished debrisoquine 4-hydroxylase activity because of the presence of a C(188)-->T mutation in exon 1.
METHODS: One hundred nineteen Hong Kong Chinese subjects were genotyped by means of allele-specific PCR, PCR, and restriction enzyme analysis for 10 CYP2D6 alleles (CYP2D6*1, *2, *4D, *5, *8/*14, *10A, *10B, *15, *16, and J9).
RESULTS: CYP2D6*10B was the most prevalent allele, and CYP2D6*10/CYP2D6*10 was the most frequent genotype, representing 41.17% [corrected] of the population.
CONCLUSIONS: There was no significant difference in the prevalence of the alleles analyzed between our study and the Chinese populations genotyped previously. This is the largest study in terms of the number of CYP2D6 alleles analyzed in an Oriental population and the first one conducted in a Hong Kong Chinese population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620567

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines.

Authors:  Michael O Baclig; Rey Z Predicala; Cynthia A Mapua; Jingky P Lozano-Kühne; Maria Luisa G Daroy; Filipinas F Natividad; Francis O Javier
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects.

Authors:  Ophelia Qi Ping Yin; Valiant Wah Lun Mak; Miao Hu; Benny Siu Pong Fok; Moses Sing Sum Chow; Brian Tomlinson
Journal:  Eur J Clin Pharmacol       Date:  2012-01-27       Impact factor: 2.953

3.  CYP2D6 allele frequencies, copy number variants, and tandems in the population of Hong Kong.

Authors:  Wing Chan; Man S Li; Senthil K Sundaram; Brian Tomlinson; Pik Y Cheung; Chi H Tzang
Journal:  J Clin Lab Anal       Date:  2018-08-01       Impact factor: 2.352

4.  Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia.

Authors:  Kai-fa Tang; Yi-li Zhao; Shang-shu Ding; Qi-fei Wu; Xing-yang Wang; Jia-qi Shi; Fa Sun; Jun-ping Xing
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

5.  Breast cancer: a neglected disease for the majority of affected women worldwide.

Authors:  Ophira M Ginsburg; Richard R Love
Journal:  Breast J       Date:  2011-03-16       Impact factor: 2.431

Review 6.  Pharmacogenetics of solid tumors: directed therapy in breast, lung, and colorectal cancer: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

Authors:  Christine L H Snozek; Dennis J O'Kane; Alicia Algeciras-Schimnich
Journal:  J Mol Diagn       Date:  2009-07-30       Impact factor: 5.568

7.  Stable expression of human cytochrome P450 2D6*10 in HepG2 cells.

Authors:  Jian Zhuge; Ying-Nian Yu; Xiao-Dan Wu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

8.  Relationship between Type A and B personality and debrisoquine hydroxylation capacity.

Authors:  S H Gan; R Ismail; W A Wan Adnan; W Zulmi; N Kumaraswamy; E T Larmie
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

9.  CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction.

Authors:  Ksenia Goryachkina; Aleksandra Burbello; Svetlana Boldueva; Svetlana Babak; Ulf Bergman; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2008-07-22       Impact factor: 2.953

Review 10.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.